Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.17 (
CaMKII
)
4,029
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Neurogenic differentiation factor 2
(
NeuroD2
) is a highly expressed transcription factor in the developing central nervous system. In newborn neurons,
NeuroD2
-mediated gene expression promotes differentiation, maturation, and survival. In addition to these early, cell-intrinsic developmental processes,
NeuroD2
in postmitotic neurons also regulates synapse growth and ion channel expression to control excitability. While
NeuroD2
transactivation can be induced in an activity-dependent manner, little is known about how expression of
NeuroD2
itself is regulated. Using genome-wide, mRNA-based microarray analysis, we found that
NeuroD2
is actually one of hundreds of genes whose mRNA levels are suppressed by synaptic activity, in a manner dependent upon N-methyl d-aspartate receptor (NMDAR) activation. We confirmed this observation both in vitro and in vivo and provide evidence that this happens at the level of transcription and not mRNA stability. Our experiments further indicate that suppression of
NeuroD2
message by NMDARs likely involves both
CaMKII
and MAPK but not voltage-gated calcium channels, in contrast to its mechanism of transactivation. We predict from these data that NMDARs may transduce information about the level of synaptic activity a developing neuron receives, to down-regulate
NeuroD2
and allow proper maturation of cortical circuits by suppressing expression of neurite and synaptic growth promoting gene products.
...
PMID:Synaptic activity suppresses expression of neurogenic differentiation factor 2 in an NMDA receptor-dependent manner. 2852 67